CN102229647A - Amino acid sequence of synovium-derived mesenchymal stem cell affinity peptide, screening method and application - Google Patents

Amino acid sequence of synovium-derived mesenchymal stem cell affinity peptide, screening method and application Download PDF

Info

Publication number
CN102229647A
CN102229647A CN2011101536328A CN201110153632A CN102229647A CN 102229647 A CN102229647 A CN 102229647A CN 2011101536328 A CN2011101536328 A CN 2011101536328A CN 201110153632 A CN201110153632 A CN 201110153632A CN 102229647 A CN102229647 A CN 102229647A
Authority
CN
China
Prior art keywords
mesenchymal stem
stem cells
cell
phage
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011101536328A
Other languages
Chinese (zh)
Other versions
CN102229647B (en
Inventor
敖英芳
邵振兴
皮彦斌
张辛
周春燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University Third Hospital
Original Assignee
Peking University Third Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University Third Hospital filed Critical Peking University Third Hospital
Priority to CN 201110153632 priority Critical patent/CN102229647B/en
Publication of CN102229647A publication Critical patent/CN102229647A/en
Priority to PCT/CN2011/084337 priority patent/WO2012167587A1/en
Application granted granted Critical
Publication of CN102229647B publication Critical patent/CN102229647B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses an amino acid sequence of synovium-derived mesenchymal stem cell affinity peptide, a screening method and an application and belongs to the field of bio-pharmaceuticals. The screening method comprises the following steps: utilizing a phage display process to respectively perform negative screening of human fibroblasts and positive screening of a synovium-derived mesenchymal stem cell; after screening, extracting the synovium-derived mesenchymal stem cell, and then decomposing the cell; extracting a phage segment which has specific affinity to the synovium-derived mesenchymal stem cell; and sequencing the phage segment, thereby acquiring a peptide segment which has high affinity to the synovium-derived mesenchymal stem cell. The amino acid sequence of synovium-derived mesenchymal stem cell affinity peptide can be used for promoting the specific affinity of biological material to the synovium-derived mesenchymal stem cell and has profound significance and wide application prospect in the field of repairing tissue engineered cartilages.

Description

The affine amino acid sequence of polypeptide of synovial membrane mesenchyme parent stem cell, screening method and application
Technical field
The invention belongs to biomedical sector, the affine amino acid sequence of polypeptide of particularly a kind of synovial membrane mesenchyme parent stem cell, screening method and application.
Background technology
Through nearly 20 years development, (Tissue Engineering, TE) art has been widely used in clinical every field to organizational project, comprises the regeneration and the reparation of osseous tissue, cartilage, nerve, blood vessel, skin and gi tract and urogenital system.In the evolution of organizational project, at the support of various tissues update and renewal is crucial, comprise renewal, the improvement of making method and the constantly bringing forth new ideas of Construction Idea of material.And the transformation on recent another apparent in view theory of organizational engineering, be exactly " abbreviation ", promptly with its at the external composition that goes to simulate healthy tissues as much as possible by the means and the technology of various complexity, and then implant, not as the support of a self-regeneration is provided for human body, allow this natural " bio-reactor " of human body depend on this support and carry out self-regeneration.Because the human internal environment is very complicated, thus just can cause a lot of experiment imaginations to differ greatly with the result, and support implantation step complicated also can be limited its promotion and application clinically.But such support will rooting carry out specific modification according to needs, thereby play the effect of inducing specific cells to adhere to, breed and break up.
In the healthy tissues, the biological function of cell peripheral matrix pair cell has great importance, functional domain by albumen in the matrix or peptide molecule combines with cell surface receptor, the signal path of complexity in the activating cells, biological functions such as the genetic expression of pair cell, adhesion, migration, propagation and differentiation are regulated and control, and perhaps these functional domains only have only the segmental length of several amino acid.This control methods for we make up the active polypeptide sequence, are carried out finishing to tissue engineering bracket, provide theoretical foundation with the adjusting function of matrix pair cell around the analog cell itself.Adopt dissimilar polypeptide that support is modified, also give support different biological functions.There are some researches show, adopt the cell peripheral stromatin that man-made support is carried out finishing, can improve attaching rate and the proliferation rate of cell to support, further discover, in these cell peripheral stromatins, fibronectin (fibronectin) is to promote that cell attaches, the main component of migration.What in fact, really influence the cell biological function is the functional domain that the several amino acid fragment constitutes in the fibronectin.For example, adopt rgd peptide that support is modified, can improve the attaching rate of myocyte, also improved the proliferate efficiency of cell, illustrate that the structural domain that only needs three amino acid fragment length just can cellular function produce remarkably influenced support.4 people such as Duan also have similar discovery, after utilizing corneal cell pathoklisis peptide sequence that support is modified, can improve the attaching rate of corneal epithelial cell, and induce corneal cell to arrange, the weave construction under the physiological conditions occur being similar at the support higher slice to support.Simultaneously, utilize polypeptide that support is modified, the gathering of also adjustable protein molecular on tissue engineering bracket, the small molecular protein that people such as Ryadnov utilize the multiple polypeptides fragment to make up is modified support, the affinity of utilizing polypeptide that the specific protein molecule is shown, give the function that support is caught these protein moleculars, make protein molecular in a frame peripheral enrichment, and then the biological function of regulation and control support inner cell.People such as Shah utilize the highly affine peptide sequence of TGF-β that the facultative molecule nano support of polypeptide (PA) is modified, greatly improved the repairing effect of support to cartilage defect, this support strengthens greatly to the inducibility of stem cell to the cartilage directed differentiation, and the expression degree of mucopolysaccharide also significantly improves.Support after peptide modified is described; can load, protect; and slowly-releasing somatomedin; this slow releasing function; closely related with the degradation time and the affine polypeptide of support to the degree of modification of support; when degree of modification was 5%-10%, after the 4th week that implanted, support still can be brought into play good growth factor slow-release function.And most critical is, the support that loads exogenous TGF-β and do not reprint exogenous TGF-β does not have marked difference to the final repairing effect of cartilage defect, this illustrates the affine support after peptide modified of this TGF-β, under the situation of not loading the exogenous growth factor, the endogenic TGF-β of enrichment somatomedin in a large number, improve the microenvironment in the support, realize the function of induced dry-cell to the cartilage differentiation.
Synovial Mesenchymal Stem Cells (SMSC) is as the newcomer in mescenchymal stem cell (MSC) family, from synovial tissue, successfully extract first in calendar year 2001 by De Bariet al. the earliest, passed through the research in nearly ten years, Synovial Mesenchymal Stem Cells has with the similar multidirectional differentiation potential of mescenchymal stem cell and is confirmed by numerous experiments, and Synovial Mesenchymal Stem Cells is compared other tissue-derived mescenchymal stem cells and is had stronger proliferation activity, its multidirectional differentiation potential is subjected to donor age, the influence of passage number and preservation preserving type is also less relatively, the position of drawing materials is also comparatively wide in range, the what is more important The experimental results shows that Synovial Mesenchymal Stem Cells has the stronger potential to chondrocyte's differentiation compared to other tissue-derived mescenchymal stem cells.
In realizing process of the present invention, the contriver find prior art exist at least following between topic: the screening method that does not also have the affine polypeptide of a kind of synovial membrane mesenchyme parent stem cell in the prior art, this method can improve biomaterial for Synovial Mesenchymal Stem Cells specificity affinity, in tissue engineering bone/cartilage reparation field profound significance and application prospects is arranged.
Summary of the invention
The purpose of the embodiment of the invention is the defective at above-mentioned prior art, and a kind of screening method that can improve biomaterial for the affine polypeptide of synovial membrane mesenchyme parent stem cell of Synovial Mesenchymal Stem Cells specificity affinity is provided.
Another purpose of the present invention provides synovial membrane mesenchyme parent stem cell affine amino acid sequence of polypeptide.
Another object of the present invention provides the application of the affine polypeptide of synovial membrane mesenchyme parent stem cell.
The technical scheme taked of the present invention is to achieve these goals:
A kind of improved display technique of bacteriophage screening can the raising biomaterial of method utilize to(for) the affine polypeptide of synovial membrane mesenchyme parent stem cell of Synovial Mesenchymal Stem Cells specificity affinity may further comprise the steps:
(1) people's Synovial Mesenchymal Stem Cells and human fibroblasts former be commissioned to train foster: be commissioned to train by people's Synovial Mesenchymal Stem Cells former and support and to pass a generation, obtain the positive-selecting cell; Former being commissioned to train by the human fibroblasts supported and passed more than ten generations, obtains negative screening cell;
(2) negative screening: in feminine gender screening cell, add phage library, remove in the phage library with P10 for ACL inoblast bonded polypeptide fragment;
(3) positive-selecting: in the positive-selecting cell, add the phage polypeptide library bacterium liquid that obtains after the negative screening in the step (2), the Synovial Mesenchymal Stem Cells of acquisition behind positive-selecting, this cell combine in the phage library and the affine polypeptide fragment of its specificity bonded;
(4) phage amplification: extraction step 3 gained Synovial Mesenchymal Stem Cells, the preparation cell pyrolysis liquid increases to the phage titre in it;
(5) titre of the phage extracting solution after the measurement amplification, 4 ℃ of preservations;
More than (1)～(5) steps repeat 4 and take turns, the 1st takes turns screening adds phage library stoste, later every take turns add last
Phage extracting solution after the amplification of wheel cells lysate;
(6) extract that each takes turns gained with the affine phage DNA fragment of Synovial Mesenchymal Stem Cells specificity, check order, filter out the peptide sequence that Synovial Mesenchymal Stem Cells is had high affinity: i.e. SEQ ID NO.1:LTHPRWP in the sequence table, its dna sequence dna is shown in the SEQ ID NO.2 in the sequence table: CTTACGCATCCTCGTTGGCCT.
Another technical scheme of the present invention is the application and the modifying method thereof of the affine peptide modified implant into body support of synovial membrane mesenchyme parent stem cell, may further comprise the steps: with 3 ' C-terminal of the affine polypeptide of Synovial Mesenchymal Stem Cells selected, connect a halfcystine (C), utilize this halfcystine (C) residue and the surface-NH of polycaprolactone (PCL) electrospinning cortina after ammonification 2Covalency coupling connection makes PCL nanofiber membrane support have the performance of specific enrichment Synovial Mesenchymal Stem Cells.
Specifically may further comprise the steps:
1) the PCL nano fibrous membrane is placed Virahol configuration 10%w/v 1, in the 6-hexanediamine, 37 ℃, place 1h;
2) by linking agent (4-(N-maleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC)) 4-[N-maleimide ylmethyl] hexanaphthene-1-carboxyl sulfosuccinimide is connected the amino on PCL nano fibrous membrane surface with affine polypeptide.
Step is more specifically:
1) the PCL nano fibrous membrane is trimmed to the circle that equates with the hole area of 24 orifice plates, puts it into then in the hole of 24 orifice plates, every hole add 500 μ l 10%w/v 1,6-hexanediamine/aqueous isopropanol, is placed 1h by 37 ℃;
2) rinsed with deionized water is 3～5 times, distilled water rinsing 3～5 times, PBS (0.01M, pH 7.4) flushing 3 times;
3) every hole adds linking agent 4-(N-maleimide ylmethyl) hexanaphthene-1-carboxylic acid-3-sulfosuccinimide ester (1mg/ml SMCC, Thermo company) of 400 μ l, places 1h under the room temperature;
4) with damping fluid (PBS+18.612gEDTA of 500ml 0.01M/pH 7.4, pH 7.2～7.5) flushing that contains EDTA 3 times
5) polypeptide solution of adding 0.1mg/ml (with the above-mentioned damping fluid configuration that contains EDTA), every hole 400 μ l, 4 ℃ are spent the night;
6) rinsed with deionized water is 3 times ,-20 ℃ of pre-freezes, 4 ℃ of preservations behind the vacuum-freeze-dry.
The beneficial effect that the technical scheme that the embodiment of the invention provides is brought is:
1, obtains the specific affine polypeptide fragment of Synovial Mesenchymal Stem Cells by display technique of bacteriophage, enable target ground and Synovial Mesenchymal Stem Cells height affinity.
2, by affine polypeptide fragment and PCL electrospinning cortina are carried out covalency coupling connection, thereby PCL nano fibrous membrane surface is modified, enable enrichment Synovial Mesenchymal Stem Cells specifically, make when this material carries out the regenerating bone or cartilage reparation in vivo as support, can routinely adhere to Synovial Mesenchymal Stem Cells, and produce normal cell epimatrix (ECM), thereby reach better repairing effect.
3, find that in the process of this polypeptide being carried out the species specificity evaluation this polypeptide there is no tangible species specificity, so this affine peptide sequence also can be widely used in various cytologic experiments and the experimentation on animals, as a kind of affiliation carrier that screens Synovial Mesenchymal Stem Cells, can screen more efficiently, the purifying Synovial Mesenchymal Stem Cells.
Description of drawings
Fig. 1 is that former being commissioned to train of people's Synovial Mesenchymal Stem Cells that provides in the embodiment of the invention 1 supported figure as a result;
Fig. 2 a, Fig. 2 b and Fig. 2 c are the phage locus coeruleus experimental results that provides during the phage titre of the embodiment of the invention 1 is measured; Phage behind the doubling dilution 10 μ l are added in the 200 μ l Escherichia coli bacteria liquids hatched 1-5 minute, add the rapid mixing of top layer substratum, on the LB-tet culture plate of tiling tetracyclin resistance, 37 ℃, 5%CO 2Spend the night, calculate the phage locus coeruleus number on the flat board.Multiply by plaque forming unit (pfu) titre that dilution factor promptly obtains per 10 μ l phages with this number then.And the single locus coeruleus of picking increases the order-checking of extraction phage DNA in LB/ intestinal bacteria nutrient solution.Fig. 2 a: locus coeruleus quantity 10 0Fig. 2 b: locus coeruleus quantity 10 1Fig. 2 c: locus coeruleus quantity 10 2
Fig. 3 is the rate of recovery of the phage of the four-wheel screening that provides in the screening of the affine polypeptide of the phage of the embodiment of the invention 1;
Fig. 4 a is the fluidic cell detected result figure of the people's that provides of the embodiment of the invention 2 the affine polypeptide of MSC;
Fig. 4 b be at Fig. 4 a the quantitative analysis results figure of fluorescence intensity;
Referring to Fig. 4 a and Fig. 4 b, affine polypeptide of the fluorescently-labeled Synovial Mesenchymal Stem Cells of the FITC of 1nM (SMSC-affinity peptide sequence) and mispairing polypeptide (Scramble peptide) carry out flow cytometry after hatching 1 hour with Synovial Mesenchymal Stem Cells respectively; By Fig. 4 b as seen, the mispairing polypeptide and the Synovial Mesenchymal Stem Cells of FITC mark are hatched jointly, and average fluorescent strength is 5; The affine polypeptide and the Synovial Mesenchymal Stem Cells of FITC mark are hatched jointly, and average fluorescent strength is 174, and the fluorescence intensity of affine polypeptide group (174) is far above the fluorescence intensity (5) of mispairing polypeptide group;
Fig. 5 a is the fluidic cell detected result figure of the affine polypeptide of MSC of the rat that provides of the embodiment of the invention 2;
Fig. 5 b be at Fig. 5 a the quantitative analysis results figure of fluorescence intensity;
Fig. 5 c is the fluidic cell detected result figure of the affine polypeptide of MSC of the rabbit that provides of the embodiment of the invention 2;
Fig. 5 d be at Fig. 5 c the quantitative analysis results figure of fluorescence intensity;
Referring to Fig. 5 a and Fig. 5 b, rat (Rat): the mispairing polypeptide and the rat Synovial Mesenchymal Stem Cells of FITC mark are hatched jointly, and average fluorescent strength is 4; The affine polypeptide and the rat Synovial Mesenchymal Stem Cells of FITC mark are hatched jointly, and average fluorescent strength is 99, and the fluorescence intensity of affine polypeptide group (99) is far above the fluorescence intensity (4) of mispairing polypeptide group;
Referring to Fig. 5 c and 5d, rabbit (Rabbit): the mispairing polypeptide and the rabbit Synovial Mesenchymal Stem Cells of FITC mark are hatched jointly, and average fluorescent strength is 5; The affine polypeptide and the rabbit Synovial Mesenchymal Stem Cells of FITC mark are hatched jointly, and average fluorescent strength is 92, and the fluorescence intensity of affine polypeptide group (92) is far above the fluorescence intensity (5) of mispairing polypeptide group;
Wherein, among Fig. 4 a, Fig. 5 a and Fig. 5 c, what the peak on the left side was represented is the mispairing polypeptide, and what the peak on the right was represented is affine polypeptide.
Fig. 6 is the laser confocal microscope observations that the embodiment of the invention 2 provides; The affine polypeptide of flag F ITC and mispairing polypeptide are hatched 1h jointly with Synovial Mesenchymal Stem Cells respectively, and Phalloidine is redyed cytoskeleton, and hochest redyes karyon, and the laser confocal microscope observation of cell combines situation with polypeptide; The result shows that affine peptide sequence (LTHPRWP) is significantly higher than mispairing polypeptide (PRHLPTW) for the avidity of Synovial Mesenchymal Stem Cells;
Fig. 7 be the embodiment of the invention 3 provide utilize the covalent attachment mode, affine polypeptide fragment is connected to the synoptic diagram on polycaprolactone (PCL) nanometer electricity spinning fibre film surface;
Fig. 8 is that the polypeptide that PCL nanometer electricity spinning fibre film that the Synovial Mesenchymal Stem Cells specific polypeptide that provides of the embodiment of the invention 3 is modified is observed under laser confocal microscope connects;
Show among the figure: connected polycaprolactone (PCL) nanofiber of the affine polypeptide fragment (LTHPRWP) of FITC mark, the visible green fluorescence intensity is higher, points out higher joint efficiency;
Fig. 9 a and Fig. 9 b are the effects that the Synovial Mesenchymal Stem Cells specific polypeptide that provides of the embodiment of the invention 3 is modified PCL nanometer electrospinning silk support; Fig. 9 a is for having connected the affine polypeptide fragment of Synovial Mesenchymal Stem Cells; Fig. 9 b is for having connected the mispairing polypeptide fragment;
Polycaprolactone (PCL) nano fibrous membrane that will connect affine polypeptide fragment of Synovial Mesenchymal Stem Cells (LTHPRWP) and mispairing polypeptide fragment (PRHLPTW) respectively places the Synovial Mesenchymal Stem Cells suspension, co-cultivation, the result shows: the PCL nano fibrous membrane that has connected affine polypeptide is compared adhesion and the growth that the PCL nano fibrous membrane that connects the mispairing polypeptide more helps Synovial Mesenchymal Stem Cells.(blue 1:hochest-karyon; Green 2: the PCL nano fibrous membrane that connects polypeptide; Red 3: Phalloidine-cytoskeleton).
Embodiment
For making the purpose, technical solutions and advantages of the present invention clearer, embodiment of the present invention is described further in detail below in conjunction with accompanying drawing.
Embodiment 1
The affine peptide sequence of display technique of bacteriophage screening Synovial Mesenchymal Stem Cells:
(1) people's Synovial Mesenchymal Stem Cells and human fibroblasts former be commissioned to train foster:
A. former being commissioned to train of people's Synovial Mesenchymal Stem Cells supported and gone down to posterity
From the corrective surgery process of accepting total knee replacement (TKA), obtain the synovial tissue in the knee joint suprapatellar bursa, put among the PBS (0.01M, pH 7.4) and wash 2 times, synovial tissue is shredded with eye scissors, add pancreatin, 37 ℃ of digestion 30min remove film sex organization; Centrifugal, supernatant liquor is abandoned in PBS (0.01M, pH 7.4) washing, adds 37 ℃ of digestion of 0.2%I Collagen Type VI enzyme 2 hours; Centrifugal, PBS (0.01M, pH 7.4) washing 2 times adds DMEM (LG) perfect medium that contains 10%FBS, changes nutrient solution one time in 2～3 days, and passes a generation, as positive-selecting cell (referring to Fig. 1).Wherein DMEM is a kind of substratum that contains each seed amino acid and glucose.
B. former being commissioned to train of human fibroblasts supported and gone down to posterity
From the corrective surgery process of accepting total knee replacement (TKA), obtain ACL (people's anterior cruciate ligament) tissue, PBS (0.01M, pH 7.4) flushing, remove the film sex organization and the blood clot on surface, with eye scissors it is shredded, remove impurity with trysinization 30min down for 37 ℃, add perfect medium and end digestion, PBS (0.01M, pH 7.4) wash 2 times, add 0.2%I Collagen Type VI enzyme (preparing with DMEM) again, 37 ℃ digested 2-3 hour, per hour put 37 ℃ of constant temperature vibration casees vibration 5min, be macroscopic floss up to the tissue block major part, observation of cell is most of under the inverted microscope separate after, blow and beat gently with the elbow suction pipe, add isopyknic perfect medium with in and collagenase, postdigestive cell suspension is through centrifugal, after abandoning supernatant liquor, resuspended with perfect medium, bed board, and pass more than ten generations.As feminine gender screening cell.
(2) negative screening (removal and P10 are for ACL inoblast bonded polypeptide fragment):
A. get a ware P10 for the ACL inoblast, with trysinization, PBS (0.01M, pH 7.4) washing 2～3 times; Add blocking buffer (sealing damping fluid, 0.1M NaCO 3(pH8.6), 5mg/ml BSA, 0.02%NaN 3) be resuspended in the 1mlEP pipe, 4 ℃ of sealing 1h reduce non-specific binding;
It is b. centrifugal that (1500rpm 5min), abandons supernatant liquor, adds the serum-free DMEM (HG) of 0.5ml, cell counting (2 * 10 6);
C. the phage library (PH.D.-7TM PHage Display Library, NEB) (1 * 10 that add 1 μ l 11PFU/10 μ l phage stoste, 100 μ l), room temperature is placed 30min;
It is d. centrifugal that (10000rpm 5min), draws supernatant liquor, obtains the phage polypeptide library bacterium liquid after feminine gender is screened, and moves in the new EP pipe standby;
(3) positive-selecting:
A. get a ware P1 for the people SMSC (Synovial Mesenchymal Stem Cells) that originates, use trysinization, PBS (0.01M, pH 7.4) washing 2～3 times; Add blocking buffer and be resuspended in the 1ml EP pipe, 4 ℃ of sealing 1h reduce non-specific binding;
B. centrifugal, abandon supernatant liquor, add the serum-free DMEM (HG) of 0.5ml, cell counting (2 * 10 6);
C. add the phage polypeptide library bacterium liquid after step (2) gained feminine gender is screened, room temperature is placed 30min;
D. centrifugal, abandon supernatant liquor, PBS washing 2～3 times obtains the cell behind the positive-selecting;
(4) phage amplification (referring to PH.D.-7TM PHage Display Peptide Library Kit operational manual):
A. with the cell preparation cell pyrolysis liquid behind step (3) the gained positive-selecting, the phage titre in it is increased: the lysis extracting solution is added in the 20ml ER2738 nutrient solution (being in early-log), rock, hatched 4.5 hours at 37 ℃;
B. the nutrient solution in the step 1) is added in the centrifuge tube, under 4 ℃, 10, centrifugal 10 minutes of 000rpm moves into supernatant in the new pipe, recentrifuge (10,000rpm, 10min);
C. extract 80% supernatant, move on in the new centrifuge tube, add the PEG/NaCl of 1/6 volume, allow phage precipitate down and spend the night at 4 ℃;
D. next day, 10,000rpm, phage bacterium liquid is centrifugal under 4 ℃, 15 minutes, abandon supernatant, (10,000rpm 10min), abandons supernatant liquor to recentrifuge;
E is with suspend again phage precipitation of 1ml TBS (50mM Tris-HCl (pH7.5), 150mM NaCl), under 4 ℃, and centrifugal 5 minutes.
F. supernatant is moved on in the new centrifuge tube, precipitate once more with the PEG/NaCl of 1/6 volume.Hatched 60 minutes on ice.4 ℃, 10, centrifugal 10 minutes of 000rpm abandons supernatant liquor, and is of short duration again centrifugal, abandons supernatant once more.
G. (pH7.5 contains 0.02%NaN to use the TBS of 200 μ l 3) precipitation that suspends again, centrifugal 1 minute, supernatant is moved on in the new centrifuge tube.This is the phage extracting solution after the amplification.
(5) phage titre is measured (referring to PH.D.-7TM PHage Display Peptide Library Kit operational manual):
A. inoculate the single bacterium colony of ER2738 in 5-10ml LB substratum, 37 ℃, the 250rpm shaking table is hatched to mid-log phase (OD6 00:～0.5).
B. microwave oven heating and melting top-layer agar is divided into 3ml/ part branch and installs in the sterilization test tube, each dilution phage one pipe.Be stored in 45 ℃ standby.
C.37 ℃ pre-temperature LB/IPTG/Xgal flat board, it is standby that each phage dilution gradient is got a flat board.
D. with the LB nutrient solution phage is carried out the dilution of 10 multiple proportions row.Suggestion dilution range: the phage culture supernatant of amplification: 10 8-10 11Kuo Zeng elutriation eluate not: 10 1-10 4Each extent of dilution changes a fresh suction nozzle, and suggestion uses band filter core suction nozzle to avoid crossed contamination.
E is divided into 200 μ l/ equal portions in Eppendorf tube when Escherichia coli bacteria liquid reaches mid-log phase, and each phage extent of dilution is managed with one.
F. add the phage of the different extension rates of 10 μ l in every pipe Escherichia coli bacteria liquid respectively, shake mixing fast, room temperature incubation 1-5min.
G. the Escherichia coli bacteria liquid with phage-infect adds in the top-agar culture tube of 45 ℃ of pre-temperature, each pipe, and mixing is poured on the LB/IPTG/Xgal flat board of 37 ℃ of pre-temperature immediately fast.Suitably tilt flat plate evenly spreads out top-layer agar.
H. after treating dull and stereotyped cooling 5min, be inverted in 37 ℃ of incubators, overnight incubation.
I checks dull and stereotyped, counting has～and 10 2Spot number on the flat board of individual plaque (referring to Fig. 2 a, Fig. 2 b and Fig. 2 c).Then, multiply by plaque forming unit (pfu) titre that dilution factor promptly obtains per 10 μ l phages with this number.
More than (1)～(5) steps repeat 4 and take turns, then each phage extracting solution of taking turns is checked order.
(6) phage polypeptide sequencing fragment (referring to PH.D.-7TM PHage Display Peptide Library Kit operational manual):
A. the amplification of plaque: intestinal bacteria are expanded enrichment liquid (OD:0.5) by usefulness LB nutrient solution dilution in 1: 100, each plaque to be checked order clone packing one pipe, 1ml/ pipe;
B. with sterilization toothpick or suction nozzle, the blue bacterial plaque of picking mono-clonal is put into above-mentioned 1ml culture tube in the plate of bacterial plaque number between 10-100.Be total to 20 mono-clonals of picking.
C.37 ℃, the 250rpm shaking table is hatched 4.5-5h;
D. the phage bacterium liquid after hatching changes in the centrifuge tube, centrifugal 30 seconds.Supernatant moves into new pipe, and is centrifugal again.Draw 80% supernatant liquor and change new centrifuge tube over to, this is amplification phage storage liquid, can 4 ℃ stores several weeks and little to the titre influence.After long storage is used sterile glycerol dilution in 1: 1 ,-20 ℃ of storages;
E. from the mono-clonal phage bacterium liquid of above-mentioned amplification, draw 500 μ l in new centrifuge tube;
F. add 200ul PEG/NaCl, put upside down mixing, room temperature is placed 10min;
G. centrifugal 10min abandons supernatant liquor, and of short duration once more centrifugal (10000rpm 30sec) inhales and to remove remaining supernatant liquor;
H. the phage precipitation thoroughly is resuspended in the 100 μ l iodide damping fluids, adds 250 μ l ethanol.Incubated at room 10min
I. centrifugal 10min abandons supernatant liquor.Ethanol with 70% is washed precipitation, of short duration vacuum-drying;
J. precipitation is resuspended in the 20 μ l distilled waters, is phage masterplate dna solution;
K. order-checking through the four-wheel screening, obtains one group of peptide sequence that Synovial Mesenchymal Stem Cells is had high affinity.
Embodiment of the invention test-results:
A, the screening of phage is affine polypeptide: utilize phage display library (PHD.-7TM PHage Display Peptide LibraryKit; New England Biolabs), carried out 4 altogether and taken turns screening, after each screening, mensuration is obtained phage titre, multiply by bacterium liquid cumulative volume, is the phage total amount that reclaim the screening back, simultaneously, the phage after the screening is increased, adopt the phage after increasing to carry out the next round screening.First round screening: the phage stoste (titre: 1 * 10 that adds 1 μ l 13PFU/10 μ l), behind the lysing cell, extracting phage titre is 1 * 10 3PFU/10 μ l, after the phage amplification of extracting, phage titre is 1 * 10 11PFU/10 μ l; Second takes turns screening: add the phage 10 μ l after increasing, after the screening, reclaiming phage titre is 5.3 * 10 4PFU/10 μ l, amplification back titre is 1 * 10 11PFU/10 μ l; The third round screening: after the screening, reclaiming phage titre is 1.2 * 10 6PFU/10 μ l, amplification back titre is 6.0 * 10 10PFU/10 μ l; The four-wheel screening: after the screening, reclaiming phage titre is 9.0 * 10 5PFU/10 μ l.
Table 1: the phage rate of recovery:
Figure BDA0000067116890000091
Referring to Fig. 3, after four-wheel screening, obtain and comprise the affine phage of Synovial Mesenchymal Stem Cells (LTHPRWP), calculate the phage rate of recovery, and compare with phage stoste.Contain the affine polypeptide phage rate of recovery: 1.50E-05; The rate of recovery of phage stoste: 1.00E-09.The Synovial Mesenchymal Stem Cells of obtaining is affine phage body and prophage liquid phase have relatively improved 15000 times (1.50E-06/1.00E-09) to the affinity of Synovial Mesenchymal Stem Cells
B, peptide sequence The selection result
The every wheel after the screening, the phage bacterium liquid that adopts screening to obtain carries out titer determination, from the locus coeruleus number on the xgal culture plate between 10～100 at random 20 bacterium colonies of picking each the 1ml Escherichia coli bacteria liquid, increase, extract phage DNA and check order.Through the four-wheel screening, obtain the one group of peptide sequence that Synovial Mesenchymal Stem Cells is had high affinity: LTHPRWP (table 2).
Table 2 peptide sequence The selection result
Figure BDA0000067116890000092
Figure BDA0000067116890000101
By the sequencing result of last table as can be known, wherein second take turns in 20 phage mono-clonals of mensuration, 2 clones' peptide sequence is: LTHPRWP; In 20 phage mono-clonals that third round is measured, 3 clones' peptide sequence is: LTHPRWP; In 20 phage mono-clonals that four-wheel is measured, 11 clones' peptide sequence is: LTHPRWP.First round The selection result lacks specificity, so do not detect the entrained polypeptide fragment of phage in the elutriant.Therefore, after the four-wheel screening, obtain the peptide sequence that Synovial Mesenchymal Stem Cells is had high affinity: LTHPRWP.
Embodiment 2
The affine polypeptide of Synovial Mesenchymal Stem Cells is identified the affinity identification of cell aspect affinity of people and rat and rabbit source Synovial Mesenchymal Stem Cells:
(1) flow cytometry
Method: get a ware Synovial Mesenchymal Stem Cells,, digested 5 minutes with 0.05% trypsinase-0.02%EDTA, come off fully up to cell, collect suspension, 1000rpm, centrifugal 5 minutes, abandon supernatant liquor, use PBS (0.01M, pH 7.4) suspension cell once more, repeat 3 times, behind the 400 mesh filter screen filtration cells, and recentrifuge (2000rpm, 5min), abandon supernatant liquor, 0.1mlPBS (0.01M, pH 7.4) behind the suspension cell, adds affine polypeptide of SMSC (FITC-LTHPRWPC) and the mispairing polypeptide (FITC-PRHLPTWC) of 1nM again, incubated at room 1h, centrifugal (2000rpm, 5min), PBS (0.01M, pH 7.4) wash 3 times, 0.5ml PBS (0.01M, pH 7.4) moves in the fluidic cell pipe behind the suspension cell again, carries out flow cytometry.
The result: the people originate Synovial Mesenchymal Stem Cells on the 60mm plate former be commissioned to train foster, after cell confluency is greater than 90%, after hatching 1 hour with the affine polypeptide of Synovial Mesenchymal Stem Cells (FITC-LTHPRWPC) of 1nM FITC mark and mispairing polypeptide (FITC-PRHLPTWC) respectively, do flow cytometry.The mispairing polypeptide is as the blank group, and average fluorescent strength is 5; With former generation Synovial Mesenchymal Stem Cells that the affine polypeptide of Synovial Mesenchymal Stem Cells is hatched, average fluorescent strength is 174.The fluorescence intensity of polypeptide group that Synovial Mesenchymal Stem Cells is affine is 34.8 times of mispairing polypeptide, illustrates that the affine polypeptide of Synovial Mesenchymal Stem Cells has significant affinity (referring to Fig. 4 a and Fig. 4 b) to people's Synovial Mesenchymal Stem Cells cell of originating.
Equally, Synovial Mesenchymal Stem Cells with rat and rabbit source is carried out flow cytometry, by the experimental result in rat and rabbit, illustrate that the affine peptide sequence that obtains does not have species specificity, not only the Synovial Mesenchymal Stem Cells to people source has affinity, and the Synovial Mesenchymal Stem Cells in rat and rabbit source is also shown very high affinity (referring to Fig. 5 a, Fig. 5 b, Fig. 5 c and Fig. 5 d).
(2) laser confocal microscope is observed
Method: the cell climbing sheet of making Synovial Mesenchymal Stem Cells, 4% Paraformaldehyde 96 is 10min fixedly, PBS (0.01M, pH 7.4) washing 3 times, the affine polypeptide of flag F ITC and mispairing polypeptide are hatched 1h jointly with cell climbing sheet respectively, under 37 ℃, Phalloidine is redyed cytoskeleton 1h, hochest redyes karyon, and room temperature is placed 10min, combines situation by the laser confocal microscope observation of cell with polypeptide.
The result: personnel selection source Synovial Mesenchymal Stem Cells is made cell climbing sheet, 4% Paraformaldehyde 96 is 10min fixedly, PBS washing 3 times, the affine polypeptide of flag F ITC and mispairing polypeptide are hatched 1h jointly with cell climbing sheet respectively, under 37 ℃, Phalloidine is redyed cytoskeleton 1h, under the room temperature, hochest redyes karyon 10min, combine situation by the laser confocal microscope observation of cell with polypeptide, observe the distribution situation of FITC green fluorescence in the Synovial Mesenchymal Stem Cells cell, as seen the affine polypeptide of Synovial Mesenchymal Stem Cells can accumulate in a large number around the Synovial Mesenchymal Stem Cells and be inner, and the rondom polypeptide of mispairing then only has very on a small quantity by Synovial Mesenchymal Stem Cells cell endocytosis at random.Illustrate that the affine polypeptide of Synovial Mesenchymal Stem Cells has very high affinity (referring to Fig. 6) to the Synovial Mesenchymal Stem Cells in people source.
Embodiment 3
The Synovial Mesenchymal Stem Cells specific polypeptide is modified PCL nanometer electricity spinning fibre film
(1) polypeptide is synthetic: affine polypeptide LTHPRWPC of Synovial Mesenchymal Stem Cells and mispairing polypeptide PRHLPTWC (contrast) (Scilight-peptide Inc that synthetic respectively screening obtains, China), adopt the FITC fluorescence dye that polypeptide is carried out mark, for material surface is carried out covalent modification, link a cysteine residues (C) at 3 ' of polypeptide and be beneficial to simultaneously with each material imino-(NH 2) covalent attachment;
(2) PCL nanometer electricity spinning fibre film is trimmed to the circle that equates with the hole area of 24 orifice plates, puts it into then in the hole of 24 orifice plates, every hole add 500 μ l 10%w/v 1, in 6-hexanediamine/aqueous isopropanol, 37 ℃, place 1h;
(3) rinsed with deionized water is 3～5 times, distilled water rinsing 3～5 times, PBS (0.01M, PH 7.4) flushing 3 times;
(4) every hole adds linking agent 4-(N-maleimide ylmethyl) hexanaphthene-1-carboxylic acid-3-sulfosuccinimide ester (1mg/ml SMCC, Thermo company) of 400 μ l, places 1h under the room temperature;
(5) with damping fluid (PBS+18.612gEDTA of 500ml 0.01M/pH 7.4, pH 7.2～7.5) flushing that contains EDTA 3 times;
(6) polypeptide solution of adding 0.1mg/ml (with the above-mentioned damping fluid configuration that contains EDTA), every hole 400 μ l, 4 ℃ are spent the night;
(7) rinsed with deionized water is 3 times ,-20 ℃ of pre-freezes, 4 ℃ of preservations behind the vacuum-freeze-dry;
(8) laser confocal microscope is observed polypeptide connection situation (referring to Fig. 8) down.
The Synovial Mesenchymal Stem Cells specific polypeptide is modified PCL nanometer electrospinning silk stented test result:
Utilize the covalent attachment mode, affine polypeptide fragment LTHPRWP and mispairing polypeptide fragment PRHLPTW are connected to polycaprolactone (PCL) nanometer electrospinning silk rack surface (referring to Fig. 7), place the Synovial Mesenchymal Stem Cells suspension, co-cultivation.The result shows: the PCL nano fibrous membrane that has connected affine polypeptide more helps the adhesion and the growth of Synovial Mesenchymal Stem Cells compared to the PCL nano fibrous membrane that connects the mispairing polypeptide.(referring to Fig. 9 a and Fig. 9 b)
The above only is preferred embodiment of the present invention, and is in order to restriction the present invention, within the spirit and principles in the present invention not all, any modification of being done, is equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Figure IDA0000067116970000011

Claims (7)

1. the affine polypeptid acid sequence of synovial membrane mesenchyme parent stem cell is characterized in that described aminoacid sequence is the SEQ ID NO.1 in the sequence table.
2. the screening method of the affine polypeptid acid sequence of synovial membrane mesenchyme parent stem cell as claimed in claim 1 is characterized in that, may further comprise the steps:
Adopt display technique of bacteriophage to carry out human fibroblasts's the feminine gender screening and the positive-selecting of Synovial Mesenchymal Stem Cells respectively; After the screening, extract Synovial Mesenchymal Stem Cells, lysing cell extracts and the affine phage DNA fragment of Synovial Mesenchymal Stem Cells specificity again, it is checked order, can obtain the polypeptid acid sequence that Synovial Mesenchymal Stem Cells is had high affinity.
3. the screening method of the affine polypeptide of synovial membrane mesenchyme parent stem cell according to claim 2 is characterized in that, specifically may further comprise the steps:
(1) people's Synovial Mesenchymal Stem Cells and human fibroblasts former be commissioned to train foster: be commissioned to train by people's Synovial Mesenchymal Stem Cells former and support and to pass a generation, obtain the positive-selecting cell; Former being commissioned to train by the human fibroblasts supported and passed more than ten generations, obtains negative screening cell;
(2) negative screening: in feminine gender screening cell, add phage library, remove in the phage library with P10 for ACL cell bonded polypeptide fragment;
(3) positive-selecting: in the positive-selecting cell, add the phage polypeptide library bacterium liquid that obtains after the negative screening in the step (2), obtain the Synovial Mesenchymal Stem Cells behind the positive-selecting, this cell combines in the phage library and the affine polypeptide fragment of its specificity bonded;
(4) phage amplification: extraction step (3) gained Synovial Mesenchymal Stem Cells, the preparation cell pyrolysis liquid increases to the phage titre in it;
(5) titre of the phage extracting solution after the measurement amplification, 4 ℃ of preservations;
More than (1)～(5) steps repeat 4 and take turns, the 1st takes turns screening adds phage library stoste, later every phage extracting solution that adds after the amplification of previous round cell pyrolysis liquid of taking turns;
(6) extract that each takes turns gained with the affine phage DNA fragment of Synovial Mesenchymal Stem Cells specificity, check order, filter out the peptide sequence that Synovial Mesenchymal Stem Cells is had high affinity: LTHPRWP.
4. application that the affine polypeptide of synovial membrane mesenchyme parent stem cell as claimed in claim 1 is used to modify the implant into body support.
5. method with the affine peptide modified implant into body support of synovial membrane mesenchyme as claimed in claim 1 parent stem cell, it is characterized in that, may further comprise the steps: with 3 ' C-terminal of the affine polypeptide of Synovial Mesenchymal Stem Cells selected, connect a halfcystine (C), utilize this halfcystine (C) residue and the surface-NH of polycaprolactone (PCL) electrospinning cortina after ammonification 2Covalency coupling connection makes PCL nanofiber membrane support have the performance of specific enrichment Synovial Mesenchymal Stem Cells.
6. the described method of claim 5 is characterized in that, may further comprise the steps:
1) the PCL nano fibrous membrane is placed Virahol configuration 10%w/v 1, in the 6-hexanediamine, 37 ℃, place 1h;
2) by linking agent 4-(N-maleimide ylmethyl) hexanaphthene-1-carboxylic acid-3-sulfosuccinimide ester the amino on PCL nano fibrous membrane surface is connected with affine polypeptide.
7. the described method of claim 5 is characterized in that, may further comprise the steps:
1) the PCL nano fibrous membrane is trimmed to the circle that equates with the hole area of 24 orifice plates, puts it into then in the hole of 24 orifice plates, every hole add 500 μ l 10%w/v 1,6-hexanediamine/aqueous isopropanol, is placed 1h by 37 ℃;
2) rinsed with deionized water is 3～5 times, distilled water rinsing 3～5 times, PBS flushing 3 times;
3) every hole adds linking agent 4-(N-maleimide ylmethyl) hexanaphthene-1-carboxylic acid-3-sulfosuccinimide ester of 400 μ l, places 1h under the room temperature;
4) the PBS flushing is 3 times;
5) polypeptide solution of adding 0.1mg/ml, every hole 400 μ l, 4 ℃ are spent the night;
6) rinsed with deionized water is 3 times ,-20 ℃ of pre-freezes, 4 ℃ of preservations behind the vacuum-freeze-dry.
CN 201110153632 2011-06-09 2011-06-09 Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body Active CN102229647B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN 201110153632 CN102229647B (en) 2011-06-09 2011-06-09 Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body
PCT/CN2011/084337 WO2012167587A1 (en) 2011-06-09 2011-12-21 Synovial mesenchymal stem cell affinitive polypeptide, screening method and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110153632 CN102229647B (en) 2011-06-09 2011-06-09 Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body

Publications (2)

Publication Number Publication Date
CN102229647A true CN102229647A (en) 2011-11-02
CN102229647B CN102229647B (en) 2013-02-20

Family

ID=44842261

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110153632 Active CN102229647B (en) 2011-06-09 2011-06-09 Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body

Country Status (2)

Country Link
CN (1) CN102229647B (en)
WO (1) WO2012167587A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012167587A1 (en) * 2011-06-09 2012-12-13 北京大学第三医院 Synovial mesenchymal stem cell affinitive polypeptide, screening method and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009026218A2 (en) * 2007-08-17 2009-02-26 University Of Illinois Identification and use of peptide inhibitors of protein synthesis
US20090186062A1 (en) * 2005-09-02 2009-07-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of Repairing Meniscal Tears

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102229647B (en) * 2011-06-09 2013-02-20 北京大学第三医院 Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090186062A1 (en) * 2005-09-02 2009-07-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of Repairing Meniscal Tears
WO2009026218A2 (en) * 2007-08-17 2009-02-26 University Of Illinois Identification and use of peptide inhibitors of protein synthesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RYADNOV MG, WOOLFSON DN: "Fiber recruiting peptides: noncovalent decoration of an engineered protein scaffold", 《J AM CHEM SOC.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012167587A1 (en) * 2011-06-09 2012-12-13 北京大学第三医院 Synovial mesenchymal stem cell affinitive polypeptide, screening method and use thereof

Also Published As

Publication number Publication date
WO2012167587A1 (en) 2012-12-13
CN102229647B (en) 2013-02-20

Similar Documents

Publication Publication Date Title
CN102229646B (en) Amino acid sequence of bone marrow mesenchymal stem cell affinity peptide, screening method and application
Ding et al. Synthetic peptide hydrogels as 3D scaffolds for tissue engineering
Yan et al. Enhanced osteogenesis of bone marrow‐derived mesenchymal stem cells by a functionalized silk fibroin hydrogel for bone defect repair
Kretsinger et al. Cytocompatibility of self-assembled β-hairpin peptide hydrogel surfaces
Chen et al. Radially oriented collagen scaffold with SDF-1 promotes osteochondral repair by facilitating cell homing
Bhardwaj et al. Potential of silk fibroin/chondrocyte constructs of muga silkworm Antheraea assamensis for cartilage tissue engineering
Zhang et al. Human dental pulp progenitor cell behavior on aqueous and hexafluoroisopropanol based silk scaffolds
WO2020258453A1 (en) Method for preparing decellularized periosteal matrix gel material derived from natural tissues
Pu et al. The use of flow perfusion culture and subcutaneous implantation with fibroblast-seeded PLLA-collagen 3D scaffolds for abdominal wall repair
Zang et al. Perichondrium directed cartilage formation in silk fibroin and chitosan blend scaffolds for tracheal transplantation
Sangkert et al. Modified silk fibroin scaffolds with collagen/decellularized pulp for bone tissue engineering in cleft palate: morphological structures and biofunctionalities
Qiu et al. Cyclic tension promotes fibroblastic differentiation of human MSCs cultured on collagen‐fibre scaffolds
Wang et al. Self‐assembled peptide‐based hydrogels as scaffolds for proliferation and multi‐differentiation of mesenchymal stem cells
Olvera et al. Spatial presentation of tissue-specific extracellular matrix components along electrospun scaffolds for tissue engineering the bone–ligament interface
CN109847098B (en) Composite biological scaffold material for repairing bone defect
JP2020532397A (en) Tissue engineering medical device
Sangkert et al. Modified porous scaffolds of silk fibroin with mimicked microenvironment based on decellularized pulp/fibronectin for designed performance biomaterials in maxillofacial bone defect
JP2015231559A (en) Implant and therapeutic composition for treating damage and/or diseases relating to human and/or animal musculoskeletal system
Mathapati et al. Nanofibers coated on acellular tissue-engineered bovine pericardium supports differentiation of mesenchymal stem cells into endothelial cells for tissue engineering
Wu et al. Electrospun fibers immobilized with BMP-2 mediated by polydopamine combined with autogenous tendon to repair developmental dysplasia of the hip in a porcine model
Arredondo et al. Fibronectin-coating enhances attachment and proliferation of mesenchymal stem cells on a polyurethane meniscal scaffold
Li et al. Enzymatically functionalized RGD-gelatin scaffolds that recruit host mesenchymal stem cells in vivo and promote bone regeneration
Li et al. L-polylactic acid porous microspheres enhance the mechanical properties and in vivo stability of degummed silk/silk fibroin/gelatin scaffold
CN102229647B (en) Method for synovium-derived mesenchymal stem cell affinity peptide modifying stent implanted in human body
CN102858793A (en) Affinity Peptides Toward Bmp-2

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant